Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
WKWGFJFNCXAUEX
|
6.2 | Ki | 14 | Yes | |
ZKZOCMGCHIECNL
|
6.2 | IC50 | 2 | — | |
CUQIEUIMKDNKMI
|
6.2 | IC50 | 2 | — | |
DTECYEKXRKVIQZ
|
6.2 | IC50 | 2 | — | |
PRPNDHHOYWARPB
|
6.2 | IC50 | 2 | — | |
AELWDCDMPFGKBB
|
6.2 | IC50 | 2 | — | |
AVIIETUEUKVYCP
|
6.2 | IC50 | 2 | Yes | |
CHQYAWLKOUOTQO
|
6.2 | Kd | 20 | — | |
CRDNMYFJWFXOCH
|
6.2 | IC50 | 3 | Yes | |
KPFROWLXOVRLMN
|
6.2 | IC50 | 2 | — | |
RYNPAHUWYURCCW
|
6.2 | IC50 | 6 | — | |
RZUOCXOYPYGSKL
|
6.2 | Kd | 8 | — | |
WHSOGGOFMJGWDM
|
6.2 | Ki | 3 | Yes | |
YHWHYCTUDCULTF
|
6.2 | IC50 | 4 | — | |
YKGKBQYSHBGZQB
|
6.2 | IC50 | 2 | Yes | |
ZYRDOEVRNXUXJJ
|
6.2 | IC50 | 2 | — | |
DYLCISDYRDBFBG
|
6.2 | Ki | 3 | — | |
JFEXQCAPNBAVHH
|
6.2 | IC50 | 2 | — | |
NITFTDTXTHHURN
|
6.2 | IC50 | 2 | — | |
SJWUVVGOTOMGOH
|
6.2 | IC50 | 12 | — | |
BNLPAUPVSCPTDM
|
6.2 | Ki | 15 | — | |
GFOMFROIIBQABZ
|
6.2 | Ki | 7 | — | |
HZPACYSNLOCDLW
|
6.2 | Ki | 48 | — | |
JRVSFZKYQCETAH
|
6.2 | Ki | 19 | — | |
KAKGFGCTONHQJW
|
6.2 | Ki | 25 | — | |
KIEFRRZUZZNWHT
|
6.2 | Ki | 6 | — | |
KTWBYGUSEYSRND
|
6.2 | Ki | 28 | — | |
KYUYCTKUEHJRCI
|
6.2 | Ki | 3 | — | |
LWBSSNRDDDFHSH
|
6.2 | Ki | 9 | — | |
MCKPYPWHBUXLEZ
|
6.2 | Ki | 21 | — | |
MONUZQWCBUZODF
|
6.2 | Ki | 3 | — | |
NQLZEAYJHRFSCQ
|
6.2 | IC50 | 2 | — | |
OQHALFBQFMAXFZ
|
6.2 | Ki | 9 | — | |
PPLGDSLAUUXVNO
|
6.2 | IC50 | 2 | — | |
QEWSTOOMTBAUAG
|
6.2 | Ki | 17 | — | |
QKFXSCNWJZKJSJ
|
6.2 | Ki | 7 | — | |
QVIIMXQIBJRPFS
|
6.2 | IC50 | 3 | — | |
QVWXPISCAWQJJE
|
6.2 | IC50 | 2 | — | |
SPYHMOFSJGTUNP
|
6.2 | Ki | 9 | — | |
TUJUZVJICDSNLY
|
6.2 | Ki | 19 | — | |
TWCARTFPHQNBPF
|
6.2 | Ki | 16 | — | |
UCESDNAOCAZCCC
|
6.2 | IC50 | 2 | — | |
UPYHVTCMTMZKAX
|
6.2 | Ki | 12 | — | |
VARGUUBRJVQGHK
|
6.2 | IC50 | 2 | — | |
VSVWQTDDGQSGHP
|
6.2 | Ki | 51 | — | |
WXZHKVLOSBCWDY
|
6.2 | IC50 | 2 | — | |
WYCBJBMCGVVCMY
|
6.2 | Ki | 8 | — | |
XBAIEEJJCJHBDL
|
6.2 | Ki | 17 | — | |
XTVULKIROSNNTG
|
6.2 | Ki | 29 | — | |
YXUQWISLOFXNGN
|
6.2 | Ki | 16 | — |